Khyade Mahendra S, Kasote Deepak M, Vaikos Nityanand P
Department of Botany, S. N. Arts, D. J. Malpani Commerce and B.N. Sarda Science College, Sangamner 422605, Maharashtra, India.
Department of Pharmaceutical Sciences, Tshwane University of Technology, Private Bag X680, Pretoria 0001, South Africa.
J Ethnopharmacol. 2014 Apr 11;153(1):1-18. doi: 10.1016/j.jep.2014.01.025. Epub 2014 Jan 28.
Alstonia scholaris (L.) R. Br. and Alstonia macrophylla Wall. ex G. Don are two vital medicinal plant species (family: Apocynaceae). In India, the therapeutic use of Alstonia scholaris has been described in both codified and non-codified drug systems for the treatment of malaria, jaundice, gastrointestinal troubles, cancer and in many other ailments. Other species, Alstonia macrophylla has been used in conventional medicines in Thailand, Malaysia and Philippines as a general tonic, aphrodisiac, anticholeric, antidysentery, antipyretic, emmenagogue, and vulnerary agents. In India, Alstonia macrophylla is used as a substitute for Alstonia scholaris in various herbal pharmaceutical preparations. However, one certainly cannot evaluate the truthfulness of a practice (i.e. in scientific terms). In this article we discuss and summarize comparative data about traditional uses, phytochemistry, pharmacology and toxicity of Alstonia scholaris and Alstonia macrophylla. Moreover, in order to unfold future research opportunities, lacunae in the present knowledge are also highlighted.
Literature about Alstonia scholaris and Alstonia macrophylla was collected by using electronic and library search. Additionally, referred books on traditional medicine and ethnopharmacology were also utilized for receiving traditional records about both the plant species.
Both Alstonia scholaris and Alstonia macrophylla are rich in different types of bioactive alkaloids. So far, broad spectrum of in vitro and in vivo biological and pharmacological activities have been reported to both the species. Amongst them, antimicrobial and anticancer activities were promising.
The use of Alstonia macrophylla as a substitute for Alstonia scholaris is not at all justifiable as both the species are distinct from each other in their phytochemistry and pharmacology. Further detail chemical fingerprinting and metabolic studies of these two species are warranted to prevent their mutual adulteration most importantly in the context of commercial preparations.
印度萝芙木(Alstonia scholaris (L.) R. Br.)和大叶印度萝芙木(Alstonia macrophylla Wall. ex G. Don)是两种重要的药用植物物种(夹竹桃科)。在印度,印度萝芙木的治疗用途在编纂和未编纂的药物体系中均有记载,可用于治疗疟疾、黄疸、胃肠道疾病、癌症以及许多其他疾病。另一个物种大叶印度萝芙木在泰国、马来西亚和菲律宾的传统药物中被用作滋补剂、壮阳药、利胆剂、抗痢疾药、退烧药、通经药和创伤愈合剂。在印度,大叶印度萝芙木在各种草药制剂中被用作印度萝芙木的替代品。然而,人们当然无法评估一种做法的真实性(即从科学角度)。在本文中,我们讨论并总结了印度萝芙木和大叶印度萝芙木在传统用途、植物化学、药理学和毒性方面的比较数据。此外,为了揭示未来的研究机会,还强调了现有知识中的空白。
通过电子搜索和图书馆检索收集了有关印度萝芙木和大叶印度萝芙木的文献。此外,还参考了关于传统医学和民族药理学的书籍,以获取有关这两种植物物种的传统记录。
印度萝芙木和大叶印度萝芙木都富含不同类型的生物活性生物碱。到目前为止,已报道这两个物种具有广泛的体外和体内生物学及药理活性。其中,抗菌和抗癌活性很有前景。
将大叶印度萝芙木用作印度萝芙木的替代品完全不合理,因为这两个物种在植物化学和药理学方面彼此不同。有必要对这两个物种进行进一步详细的化学指纹图谱和代谢研究,以防止它们在商业制剂中相互掺假。